Integra Lifesciences (IART) Misses Q1 EPS by 30c; Trims Outlook
Tweet Send to a Friend
Integra Lifesciences Holdings (NASDAQ: IART) reported Q1 EPS of $0.39, $0.30 worse than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE